NCT06174025 is a clinical trial in Duchenne Muscular Dystrophy, sponsored by Çağtay Maden.

Who is sponsoring NCT06174025?

NCT06174025 is sponsored by Çağtay Maden.

What condition does NCT06174025 study?

NCT06174025 studies Duchenne Muscular Dystrophy.

Is NCT06174025 still recruiting?

NCT06174025 is currently completed. Last updated 12 January 2024.

Last reviewed 2024-01-12 · How we verify

NCT06174025

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Validity and Reliability of the 6 Minute Pegboard Ring Test

Completed Last updated 12 January 2024

What this trial tests

trial in Duchenne Muscular Dystrophy in 22 participants. Completed in 1 January 2024.

Timeline

30 June 2023

Primary endpoint
30 December 2023

1 January 2024

Quick facts

Lead sponsor	Çağtay Maden
Status	Completed
Study type	OBSERVATIONAL
Enrollment	22
Start date	30 June 2023
Primary completion	30 December 2023
Estimated completion	1 January 2024
Sites	1 location across Turkey (Türkiye)

Conditions studied

Duchenne Muscular Dystrophy — all drugs for Duchenne Muscular Dystrophy →

Sponsor

Çağtay Maden

Who can join

Adults 6 to 18, male only, with Duchenne Muscular Dystrophy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aimed to investigate the validity and reliability of 6PBRT in individuals with DMD and its applicability on these patients.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Validity and Reliability of the 6-min Pegboard and Ring Test in Patients With Duchenne Muscular Dystrophy.
Maden Ç, Karabulut DG, Yiğit S. · · 2025 · cited 1× · PMID 39660725 · DOI 10.1002/mus.28314

Verify or expand the search:

Other recruiting trials for Duchenne Muscular Dystrophy

Currently open trials in the same condition.

NCT07287189 — Phase 2 Study of SAT-3247 in Pediatric Ambulatory Patients · Phase 2 · recruiting
NCT06817382 — A Study to Investigate the Safety and Biodistribution of a Single Intrathecal (IT) Injection of INS1201 in Ambulatory Ma · Phase 1 · recruiting
NCT06402942 — Gamified Occupational Therapy for Adolescents With Duchenne Muscular Dystrophy · NA · recruiting
NCT06450639 — A Study to Assess the Efficacy and Safety of Satralizumab in Duchenne Muscular Dystrophy (DMD) · Phase 2 · active not recruiting
NCT06692426 — Trial of Cell Based Therapy for DMD · Phase 1 · recruiting

Other Çağtay Maden trials

Trials by the same sponsor.

NCT06172244 — Acute Effect of Whole Body Vibration on Reaction Speed and Proprioception · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06174025 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Çağtay Maden
Last refreshed: 12 January 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06174025.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing